Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Pharmacogenomic and pharmacokinetic determinants of erlotinib toxicity.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Pharmacogenomic and pharmacokinetic determinants of erlotinib toxicity.
Pharmacogenomic and pharmacokinetic determinants of erlotinib toxicity. J Clin Oncol. 2008 Mar 01; 26(7):1119-27.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
ATP-Binding Cassette Transporters
Carcinoma, Non-Small-Cell Lung
Cytochrome P-450 CYP3A
Cytochrome P-450 Enzyme System
Diarrhea
ErbB Receptors
Erlotinib Hydrochloride
Exanthema
Female
Head and Neck Neoplasms
Humans
Lung Neoplasms
Male
Middle Aged
Neoplasm Proteins
Neoplasms, Squamous Cell
Ovarian Neoplasms
Pharmacogenetics
Polymorphism, Genetic
Prospective Studies
Protein Kinase Inhibitors
Quinazolines
authors with profiles
Mark J. Ratain
Gini Fleming
Theodore Karrison
Everett E. Vokes